NASDAQ:AYLA

Ayala Pharmaceuticals News Headlines

$10.10
-0.06 (-0.59 %)
(As of 05/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.03
$10.20
50-Day Range
$10.15
$13.85
52-Week Range
$8.62
$28.68
Volume8,961 shs
Average Volume30,609 shs
Market Capitalization$133.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Ayala Pharmaceuticals (NASDAQ AYLA) News Headlines Today

SourceHeadline
Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) Short Interest UpdateAyala Pharmaceuticals, Inc. (NASDAQ:AYLA) Short Interest Update
americanbankingnews.com - May 2 at 5:16 AM
Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) Given Average Rating of "Buy" by BrokeragesAyala Pharmaceuticals, Inc. (NASDAQ:AYLA) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - May 1 at 4:34 AM
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple MyelomaAyala Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of AL102 in Combination with BCMA Targeting Agent, WVT078, in Patients with relapsed/refractory Multiple Myeloma
finance.yahoo.com - April 21 at 12:34 PM
Financial Comparison: Ayala Pharmaceuticals (NASDAQ:AYLA) & PharmaCyte Biotech (OTCMKTS:PMCB)Financial Comparison: Ayala Pharmaceuticals (NASDAQ:AYLA) & PharmaCyte Biotech (OTCMKTS:PMCB)
americanbankingnews.com - April 20 at 2:18 AM
Ayala Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Business UpdateAyala Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - March 25 at 9:10 AM
Ayala Pharmaceuticals Inc (AYLA) President & CEO Roni Mamluk Sold $617,137 of SharesAyala Pharmaceuticals Inc (AYLA) President & CEO Roni Mamluk Sold $617,137 of Shares
finance.yahoo.com - February 24 at 11:15 PM
Ayala Pharmaceuticals raises $25M from private stock saleAyala Pharmaceuticals raises $25M from private stock sale
bizjournals.com - February 24 at 6:15 PM
Ayala Pharmaceuticals To Raise $25M Via Private Stock Placement; Shares Pop 16%Ayala Pharmaceuticals To Raise $25M Via Private Stock Placement; Shares Pop 16%
finance.yahoo.com - February 22 at 1:13 PM
Ayala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue TumorsAyala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue Tumors
finance.yahoo.com - February 19 at 2:34 PM
Companies Like Ayala Pharmaceuticals (NASDAQ:AYLA) Are In A Position To Invest In GrowthCompanies Like Ayala Pharmaceuticals (NASDAQ:AYLA) Are In A Position To Invest In Growth
finance.yahoo.com - February 19 at 9:33 AM
ACIU & Alzheimers Vaccine, GNMK Rallies, ESSAs Prostate Cancer Drug On Track, MNPR On WatchACIU & Alzheimer's Vaccine, GNMK Rallies, ESSA's Prostate Cancer Drug On Track, MNPR On Watch
nasdaq.com - February 12 at 7:35 AM
NVAXs Covid Jab Shows 89.3% Efficacy In UK Trial, AZRX Awaits Data, FDA Lifts Hold On BLCM TrialNVAX's Covid Jab Shows 89.3% Efficacy In UK Trial, AZRX Awaits Data, FDA Lifts Hold On BLCM Trial
nasdaq.com - January 29 at 2:14 AM
Ayala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast CancerAyala Pharmaceuticals Announces First Patient Dosed in Phase 2 TENACITY Clinical Trial of AL101 for the Treatment of Patients with Notch-Activated Triple Negative Breast Cancer
finance.yahoo.com - January 28 at 11:10 AM
Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small & Microcap Virtual Investor ConferenceAyala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small & Microcap Virtual Investor Conference
finance.yahoo.com - January 13 at 8:55 PM
Ayala Pharmaceuticals to Present at the Virtual H.C. Wainwright Bioconnect ConferenceAyala Pharmaceuticals to Present at the Virtual H.C. Wainwright Bioconnect Conference
finance.yahoo.com - January 5 at 11:57 AM
Ayala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 StudyAyala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 Study
finance.yahoo.com - January 4 at 12:53 PM
Ayala Pharmaceuticals IncAyala Pharmaceuticals Inc
reuters.com - December 16 at 7:44 AM
Growth Investors: Industry Analysts Just Upgraded Their Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) Revenue Forecasts By 64%Growth Investors: Industry Analysts Just Upgraded Their Ayala Pharmaceuticals, Inc. (NASDAQ:AYLA) Revenue Forecasts By 64%
nasdaq.com - November 20 at 10:08 AM
Ayala Pharmaceuticals EPS misses by $0.03, beats on revenueAyala Pharmaceuticals EPS misses by $0.03, beats on revenue
seekingalpha.com - November 19 at 8:40 AM
Ayala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business UpdateAyala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - November 17 at 9:49 AM
Ayala Pharmaceuticals to Participate in Upcoming Virtual Investor ConferencesAyala Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
finance.yahoo.com - November 5 at 9:48 AM
Ayala Pharma under pressure on underwhelming AL101 data in type of cancer affecting the glandular tissuesAyala Pharma under pressure on underwhelming AL101 data in type of cancer affecting the glandular tissues
seekingalpha.com - September 18 at 1:46 PM
Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma with Notch Activating Mutations at ESMO 2020Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma with Notch Activating Mutations at ESMO 2020
finance.yahoo.com - September 18 at 8:45 AM
Ayala Pharmaceuticals to host KOL event on September 18Ayala Pharmaceuticals to host KOL event on September 18
seekingalpha.com - September 14 at 1:01 PM
Ayala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business UpdateAyala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 13 at 8:15 AM
Here's Why We're Watching Ayala Pharmaceuticals' (NASDAQ:AYLA) Cash Burn SituationHere's Why We're Watching Ayala Pharmaceuticals' (NASDAQ:AYLA) Cash Burn Situation
finance.yahoo.com - August 10 at 10:40 AM
Is Ayala Pharmaceuticals (NASDAQ:AYLA) In A Good Position To Invest In Growth?Is Ayala Pharmaceuticals (NASDAQ:AYLA) In A Good Position To Invest In Growth?
finance.yahoo.com - August 10 at 10:40 AM
Ayala Pharmaceuticals, Inc. (AYLA)Ayala Pharmaceuticals, Inc. (AYLA)
ca.finance.yahoo.com - August 1 at 7:53 PM
Ayala Pharmaceuticals to Present Updated Data from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of R/M Adenoid Cystic Carcinoma at the European Society for Medical Oncology (ESMO) Virtual Congress 2020Ayala Pharmaceuticals to Present Updated Data from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of R/M Adenoid Cystic Carcinoma at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
finance.yahoo.com - July 27 at 10:20 AM
Ayala Pharmaceuticals EPS misses by $0.23, beats on revenueAyala Pharmaceuticals EPS misses by $0.23, beats on revenue
seekingalpha.com - June 22 at 10:26 AM
Ayala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business UpdateAyala Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - June 22 at 10:26 AM
Why This Ayala Pharmaceuticals Analyst Is BullishWhy This Ayala Pharmaceuticals Analyst Is Bullish
finance.yahoo.com - June 10 at 7:11 PM
Ayala Pharmaceuticals to Present at Upcoming Investor ConferencesAyala Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - June 1 at 1:45 PM
Keros Therapeutics to Present at the Virtual 25th Annual Congress of the European Hematology AssociationKeros Therapeutics to Present at the Virtual 25th Annual Congress of the European Hematology Association
feeds.benzinga.com - May 14 at 9:19 AM
Ayala Pharmaceuticals Announces Closing of Initial Public OfferingAyala Pharmaceuticals Announces Closing of Initial Public Offering
finance.yahoo.com - May 12 at 8:41 PM
Ayala Pharmaceuticals Announces Pricing of Initial Public OfferingAyala Pharmaceuticals Announces Pricing of Initial Public Offering
finance.yahoo.com - May 12 at 9:36 AM
This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.